دورية أكاديمية
أعرض في EDS

A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine.

التفاصيل البيبلوغرافية
العنوان: A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine.
المؤلفون: Pelletier AN; RPM Bioinfo Solutions, Sainte-Thérèse, QC, Canada; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Sanchez GP; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Izmirly A; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia., Watson M; CellCarta, Montreal, QC, Canada., Di Pucchio T; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Carvalho KI; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Filali-Mouhim A; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Paramithiotis E; CellCarta, Montreal, QC, Canada., Timenetsky MDCST; Instituto Adolfo Lutz, São Paulo, Brazil., Precioso AR; Instituto Butantan, São Paulo, Brazil., Kalil J; Laboratory of Immunology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil; Institute for Investigation in Immunology-Instituto Nacional de Ciência e Tecnologia-iii-INCT, São Paulo, SP, Brazil., Diamond MS; Departments of Medicine, Molecular Microbiology, and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Haddad EK; Department of Medicine and Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA., Kallas EG; Instituto Butantan, São Paulo, Brazil; Department of Infectious and Parasitic Diseases, Hospital das Clínicas, School of Medicine, University of Sao Paulo, São Paulo 01246-903, Brazil., Sekaly RP; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: rafick.sekaly@emory.edu.
المصدر: Cell reports [Cell Rep] 2024 Jul 23; Vol. 43 (7), pp. 114370. Date of Electronic Publication: 2024 Jun 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Cambridge, MA] : Cell Press, c 2012-
مواضيع طبية MeSH: Dengue Vaccines*/immunology , Dengue Virus*/immunology , Antibodies, Viral*/immunology, Humans ; Dengue/immunology ; Dengue/prevention & control ; Dengue/virology ; Monocytes/immunology ; Monocytes/metabolism ; Antibody Formation/immunology ; Transforming Growth Factor beta/metabolism ; Transforming Growth Factor beta/immunology ; Vaccination ; Antibodies, Neutralizing/immunology
مستخلص: Protective immunity to dengue virus (DENV) requires antibody response to all four serotypes. Systems vaccinology identifies a multi-OMICs pre-vaccination signature and mechanisms predictive of broad antibody responses after immunization with a tetravalent live attenuated DENV vaccine candidate (Butantan-DV/TV003). Anti-inflammatory pathways, including TGF-β signaling expressed by CD68 low monocytes, and the metabolites phosphatidylcholine (PC) and phosphatidylethanolamine (PE) positively correlate with broadly neutralizing antibody responses against DENV. In contrast, expression of pro-inflammatory pathways and cytokines (IFN and IL-1) in CD68 hi monocytes and primary and secondary bile acids negatively correlates with broad DENV-specific antibody responses. Induction of TGF-β and IFNs is done respectively by PC/PE and bile acids in CD68 low and CD68 hi monocytes. The inhibition of viral sensing by PC/PE-induced TGF-β is confirmed in vitro. Our studies show that the balance between metabolites and the pro- or anti-inflammatory state of innate immune cells drives broad and protective B cell response to a live attenuated dengue vaccine.
Competing Interests: Declaration of interests A.-N.P. is a paid bioinformatics consultant and owner of RPM Bioinfo Solutions. M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, Ocugen, IntegerBio, GlaxoSmithKline, Allen & Overy LLP, Moderna, and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions, IntegerBio, and Moderna. E.G.K. is the current director of the Butantan Institute, which is the vaccine manufacturer. E.P. is a shareholder of CellCarta Biosciences, Inc. T.D.P. is currently employed by MacroGenics, Inc. (Rockville, MD), and received stock options as a condition of employment. R.P.S. is a member of the scientific advisory board for CellCarta.
(Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
References: Bioinformatics. 2015 Jan 15;31(2):166-9. (PMID: 25260700)
Curr Opin Virol. 2011 Dec;1(6):519-25. (PMID: 22328912)
J Exp Med. 2008 Dec 22;205(13):3119-31. (PMID: 19047440)
Antiviral Res. 2017 Nov;147:47-57. (PMID: 28965915)
Nat Immunol. 2011 Jul 10;12(8):786-95. (PMID: 21743478)
Nat Immunol. 2019 Feb;20(2):163-172. (PMID: 30643263)
Bioinformatics. 2012 Aug 15;28(16):2184-5. (PMID: 22743226)
Cell. 2014 Apr 10;157(2):499-513. (PMID: 24725414)
Clin Infect Dis. 2022 Aug 24;75(1):107-117. (PMID: 34606595)
J Biol Chem. 2003 Mar 14;278(11):9435-40. (PMID: 12524422)
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12300-6. (PMID: 25136102)
J Virol. 2008 Jan;82(1):335-45. (PMID: 17942531)
Cell. 2019 Sep 5;178(6):1313-1328.e13. (PMID: 31491384)
Arch Virol. 2013 Jul;158(7):1445-59. (PMID: 23471635)
Nat Rev Immunol. 2021 Oct;21(10):618-619. (PMID: 34580450)
Sci Rep. 2017 Apr 12;7:46416. (PMID: 28401922)
Biostatistics. 2007 Jan;8(1):118-27. (PMID: 16632515)
Biochim Biophys Acta. 2004 Aug 30;1684(1-3):18-28. (PMID: 15450206)
Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):E3976-85. (PMID: 25201965)
Cell. 2016 Jan 28;164(3):564-78. (PMID: 26824662)
PLoS One. 2009 Oct 16;4(10):e7475. (PMID: 19834619)
Mol Biol Cell. 2012 Mar;23(6):1129-39. (PMID: 22278742)
Front Immunol. 2021 Apr 16;12:642546. (PMID: 33936059)
Nucleic Acids Res. 2010 Jan;38(Database issue):D480-7. (PMID: 19948758)
Front Nutr. 2021 May 14;8:676026. (PMID: 34055860)
Bioinformatics. 2010 Oct 1;26(19):2438-44. (PMID: 20709693)
PLoS Negl Trop Dis. 2013 May 23;7(5):e2236. (PMID: 23717702)
Sci Rep. 2018 Jan 10;8(1):255. (PMID: 29321478)
Bioinformatics. 2014 Aug 1;30(15):2114-20. (PMID: 24695404)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
Vaccine. 2020 Jul 31;38(35):5572-5576. (PMID: 32654899)
Biochem J. 2005 Nov 1;391(Pt 3):549-60. (PMID: 15984932)
Nature. 2013 Apr 25;496(7446):504-7. (PMID: 23563266)
Lancet Infect Dis. 2020 Jul;20(7):839-850. (PMID: 32220283)
Science. 2017 Apr 21;356(6335):. (PMID: 28428369)
Nat Immunol. 2009 Jan;10(1):116-125. (PMID: 19029902)
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):25-36. (PMID: 30580568)
Nucleic Acids Res. 2019 Jul 2;47(W1):W212-W224. (PMID: 31114921)
Nat Rev Immunol. 2015 Aug;15(8):471-85. (PMID: 26160613)
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1558-1572. (PMID: 28411170)
Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6. (PMID: 23203888)
J Biol Chem. 2007 Sep 14;282(37):27155-27164. (PMID: 17636253)
Cell. 2021 Jun 24;184(13):3573-3587.e29. (PMID: 34062119)
Int J Mol Sci. 2013 Mar 18;14(3):6170-86. (PMID: 23507753)
Nat Immunol. 2021 Oct;22(10):1294-1305. (PMID: 34556879)
JAKSTAT. 2013 Jul 1;2(3):e23931. (PMID: 24069549)
Science. 2010 May 7;328(5979):745-8. (PMID: 20448183)
J Exp Clin Cancer Res. 2019 Jan 5;38(1):4. (PMID: 30611309)
Science. 1999 Jun 11;284(5421):1835-7. (PMID: 10364556)
Front Cell Infect Microbiol. 2020 Oct 22;10:572681. (PMID: 33194810)
Methods Mol Biol. 2011;781:257-77. (PMID: 21877285)
Nat Med. 2019 Jan;25(1):75-81. (PMID: 30478422)
Nat Med. 2020 Apr;26(4):618-629. (PMID: 32094927)
Front Immunol. 2020 Jun 18;11:1252. (PMID: 32655561)
EMBO J. 2005 Sep 21;24(18):3247-58. (PMID: 16121194)
Trends Immunol. 2015 Aug;36(8):479-93. (PMID: 26187853)
J Immunol. 2017 Jan 15;198(2):617-622. (PMID: 27940658)
PLoS Comput Biol. 2017 Nov 3;13(11):e1005752. (PMID: 29099853)
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14682-7. (PMID: 26575624)
Curr Opin Immunol. 2013 Aug;25(4):542-7. (PMID: 23953808)
Immunity. 2015 Dec 15;43(6):1186-98. (PMID: 26682988)
Cell. 2015 Jul 2;162(1):184-97. (PMID: 26095251)
Hum Vaccin Immunother. 2018;14(9):2158-2162. (PMID: 29482433)
J Exp Med. 1977 Jul 1;146(1):201-17. (PMID: 406347)
Virology. 1999 Apr 25;257(1):1-6. (PMID: 10208914)
Immunity. 2019 Apr 16;50(4):907-923. (PMID: 30995506)
Adv Virus Res. 2003;60:421-67. (PMID: 14689700)
Cell Rep. 2022 Feb 8;38(6):110341. (PMID: 35139383)
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. (PMID: 16199517)
Science. 2002 May 17;296(5571):1313-6. (PMID: 12016314)
Sci Transl Med. 2016 Mar 16;8(330):330ra36. (PMID: 27089205)
J Immunol. 2015 Jun 1;194(11):5053-60. (PMID: 25980030)
J Lipid Res. 2015 Dec;56(12):2238-47. (PMID: 26443794)
Clin Microbiol Rev. 2009 Oct;22(4):564-81. (PMID: 19822889)
Vaccine. 2017 Nov 7;35(47):6355-6358. (PMID: 29029938)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Nature. 2011 Jun 15;474(7351):327-36. (PMID: 21677749)
Microorganisms. 2019 Mar 14;7(3):. (PMID: 30875727)
J Infect Dis. 2015 Sep 1;212(5):702-10. (PMID: 25801652)
Mol Cell Biol. 2004 Feb;24(3):1411-25. (PMID: 14729983)
BMC Bioinformatics. 2013 Jan 16;14:7. (PMID: 23323831)
Lab Invest. 2017 Jan;97(1):4-13. (PMID: 27869795)
Rev Panam Salud Publica. 2021 Jun 11;45:e67. (PMID: 34131423)
Curr Opin Immunol. 2020 Aug;65:57-64. (PMID: 32504952)
Cell. 2020 Aug 20;182(4):901-918.e18. (PMID: 32668198)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Gut. 2005 Jul;54(7):966-71. (PMID: 15951544)
Front Microbiol. 2021 Sep 16;12:744233. (PMID: 34603272)
Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. (PMID: 30726743)
J Clin Invest. 1999 Jan;103(1):89-95. (PMID: 9884338)
Cell Res. 2019 Mar;29(3):193-205. (PMID: 30651583)
Nat Commun. 2016 Jan 08;7:10369. (PMID: 26742691)
PLoS Negl Trop Dis. 2011 Jan 04;5(1):e926. (PMID: 21245912)
Eur J Immunol. 2009 Dec;39(12):3315-22. (PMID: 19750484)
Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9. (PMID: 2665015)
N Engl J Med. 2015 Sep 24;373(13):1195-206. (PMID: 26214039)
J Virol. 2018 Jun 29;92(14):. (PMID: 29743372)
J Lipid Res. 2006 Mar;47(3):673-6. (PMID: 16371647)
J Biol Chem. 2010 Jul 16;285(29):22027-35. (PMID: 20489212)
Nature. 2013 Dec 19;504(7480):446-50. (PMID: 24226770)
Science. 1988 Jan 29;239(4839):476-81. (PMID: 3277268)
Vaccines (Basel). 2020 Feb 02;8(1):. (PMID: 32024238)
J Biol Chem. 2013 Jul 5;288(27):19805-15. (PMID: 23658011)
J Virol. 2008 Jan;82(2):609-16. (PMID: 17977974)
Elife. 2022 Jan 21;11:. (PMID: 35060479)
معلومات مُعتمدة: R01 AI125202 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: CP: Immunology; bile acids; dengue; immunology; systems biology; vaccine
المشرفين على المادة: 0 (Dengue Vaccines)
0 (Antibodies, Viral)
0 (Transforming Growth Factor beta)
0 (Antibodies, Neutralizing)
تواريخ الأحداث: Date Created: 20240620 Date Completed: 20240729 Latest Revision: 20240917
رمز التحديث: 20240917
مُعرف محوري في PubMed: PMC11404042
DOI: 10.1016/j.celrep.2024.114370
PMID: 38900640
قاعدة البيانات: MEDLINE
الوصف
تدمد:2211-1247
DOI:10.1016/j.celrep.2024.114370